1. Market Research
  2. > Pharmaceutical
  3. > Pharmacies and Drug Stores Market Trends
  4. > Chemists & Pharmacies European Industry Report

Chemists & Pharmacies European Industry Report

  • December 2016
  • -
  • Plimsoll Publishing Ltd UK
  • -
  • 220 pages

Plimsoll's Chemists & Pharmacies (EUROPEAN) analysis is the most definitive and accurate study of the Chemists & Pharmacies (EUROPEAN) sector in 2016.

The report is split into two sections and uses both a written and graphical analysis – analysing the 160 largest Chemists & Pharmacies (EUROPEAN) companies.

The Chemists & Pharmacies (EUROPEAN) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis.

Indeed, the first section thoroughly scrutinises the market and this section includes the following:

- Best Trading Partners: These are companies that are winning in both sales and financial strength – for example CEFARM SLASKI SP. Z O.O. has been ranked as a best trading partner in the industry.
- Sales Growth Analysis: This section reviews the fastest growing and fastest shrinking company – for example ARTROLAB is among the fastest growing.
- Profit Analysis – Analysis of gross profit and pre-tax profit over the last ten years and a profitability summary comparing profits in the industry against small, medium and large companies.
- Market Size: Based on the largest 160 companies, this is a comparison between last year's market size and the most current figure (This year the market has decreased by 8.7%).
- Rankings: The top 50 companies ranked by: Market Share, Sales Growth, Gross Profit and Pre-tax Profit.

The next section focuses on company analysis and provides an in-depth analysis of the largest companies within the Chemists & Pharmacies (EUROPEAN) industry.

Each business is analysed using Plimsoll’s unequivocal model and culminates in the production of the Plimsoll Chart. The Plimsoll Model uses a series of charts to graphically analyse an individual company and measure its ability to achieve sales growth while maintaining financial strength.

The Plimsoll Chart is a quick and dependable method of analysing a company’s financial well-being. It’s simple to understand: a rising line is good news and a falling line is bad news.

Therefore, this company analysis will tell you if a company is:

- Strong or heading for failure
- Utilising their investments
- Becoming burdened by debt
- Getting the most from their resources

The Plimsoll Chemists & Pharmacies (EUROPEAN) analysis also provides you with full business name and address, name and ages of directors and registration address.

Table Of Contents

Chemists and Pharmacies European Industry Report
Plimsoll Publishing's Chemists and Pharmacies (EUROPEAN) Analysis provides a detailed overview of the UK Chemists and Pharmacies (EUROPEAN) market and delivers a comprehensive individual analysis on the top 160 companies, including COOP-GRUPPE GENOSSENSCHAFT, ALLIANCE HEALTHCARE ITALIA S.P.A and ALDI GMBH and CO. KOMMANDITGESELLSCHAFT.

This report includes a wealth of information on the financial trends over the past four years.

Plimsoll Publishing's latest Chemists and Pharmacies (EUROPEAN) analysis is ideal for anyone wanting to:

- See the market leaders
- Identify companies heading for failure
- Seek out the most attractive acquisition
- Analyse industry trends
- Benchmark their own financial performance

Using Plimsoll's exclusive methodology, a quick glance of this Chemists and Pharmacies (EUROPEAN) report will tell you that 42 companies have a declining Plimsoll financial rating, while 6 have shown good sales growth.

Each of the largest 160 companies is meticulously scrutinised in a single paged individual assessment and is analysed using the most up-to-date and current financial data.

Every business is examined on the following features:

- The Plimsoll Chart: A graphical assessment of a company's financial performance
-
-
- Four year assessment of the profit/loss and balance sheet
- A written summary highlighting key performance issues

Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the Chemists and Pharmacies (EUROPEAN) market.

This section includes:

- Best Trading Partners
- Sales Growth Analysis
- Profit Analysis
- Market Size
- Rankings

Established in 1987, Plimsoll provides busy managers with a set of tools to monitor the financial welfare of their company, their rivals, or those they wish to acquire. The reports are used to assess the attractiveness of potential acquisitions, gain better understanding of a market and identify sound companies with whom to trade.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Pharmacy Automation: Technologies and Global Markets

Pharmacy Automation: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report provides a comprehensive analysis of the pharmacy automation market's current operations and equipment, current trends and detailed patent analysis. Structure and current market ...

Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016-2026

Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016-2026

  • $ 5000
  • Industry report
  • September 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Special purpose needles are used in target specific drug deliveries or collection of samples such as fluid and cells from organs or lumps and are available in the market with various advanced features, ...

Hypercalcemia Treatment Market: Global Industry Analysis & Opportunity Assessment, 2016-2026

Hypercalcemia Treatment Market: Global Industry Analysis & Opportunity Assessment, 2016-2026

  • $ 5000
  • Industry report
  • September 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.